Lawsuit Over Atripla, Truvada Pay-to-Delay Generics Scheme Results in Defense Verdict for Gilead, Teva
This is the third antitrust trial victory for Gilead involving claims it participated in an Atripla and Truvada pay-to-delay generics scheme
This is the third antitrust trial victory for Gilead involving claims it participated in an Atripla and Truvada pay-to-delay generics scheme
The Gilead HIV drug lawsuit filed by the Justice Department claimed the drug maker violated patents held by the CDC for the use of Truvada and Descovy as preventative treatments.